ADMA Biologics, Inc.
ADMANASDAQHealthcare● Active
$8.06
+$0.09(+1.13%)
Market Cap$1.9B
P/E Ratio—
52W High$22.37
52W Low$7.21
ADMA Biologics, Inc. (ADMA) · Balance Sheet
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · ADMA · as of 2026-06-10
Financial statements
Total Assets · Total Liabilities · Equity
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Assets | |||||
| Cash & ST Investments | $0.09B | $0.10B | $0.05B | $0.09B | $0.05B |
| Net Receivables | $0.16B | $0.05B | $0.03B | $0.02B | $0.03B |
| Inventory | $0.21B | $0.17B | $0.17B | $0.16B | $0.12B |
| Total Current Assets | $0.47B | $0.33B | $0.26B | $0.27B | $0.21B |
| PP&E Net | $0.07B | $0.06B | $0.06B | $0.07B | $0.06B |
| Goodwill | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Intangible Assets | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Total Assets | $0.62B | $0.49B | $0.33B | $0.35B | $0.28B |
| Liabilities | |||||
| Short-Term Debt | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Accounts Payable | $0.02B | $0.02B | $0.02B | $0.01B | $0.01B |
| Total Current Liabilities | $0.07B | $0.06B | $0.05B | $0.04B | $0.03B |
| Long-Term Debt | $0.08B | $0.07B | $0.13B | $0.14B | $0.09B |
| Total Liabilities | $0.15B | $0.14B | $0.19B | $0.20B | $0.14B |
| Stockholders Equity | |||||
| Retained Earnings | ($0.16B) | ($0.31B) | ($0.51B) | ($0.48B) | ($0.41B) |
| Total Stockholders Equity | $0.48B | $0.35B | $0.14B | $0.15B | $0.14B |
| Total Liab & Equity(computed) | $0.62B | $0.49B | $0.33B | $0.35B | $0.28B |
| Debt Summary | |||||
| Total Debt | $0.08B | $0.08B | $0.14B | $0.15B | $0.10B |
| Net Debt | ($0.01B) | ($0.02B) | $0.09B | $0.07B | $0.05B |
Data source: Financial Modeling Prep · Last updated: 2026-06-10 · USD · B
Explore more ADMA Biologics, Inc. data
About ADMA Biologics, Inc. (ADMA) Balance Sheet
ADMA Biologics, Inc. (ADMA) balance sheet shows total assets of $0.62B with cash of $0.09B. Total liabilities are $0.15B, total debt $0.08B, and stockholders equity $0.48B.
Frequently asked questions
ADMA · 4 questionsADMA Biologics, Inc. has total debt of $0.08B with net debt of ($0.01B).
ADMA total debtnet debtdebt to equity
· Source: FMP /stable/balance-sheet-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10